OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...

GPT-Rosalind steps in the earliest and most hypothesis-driven stages, where researchers juggle vast literature, specialised ...

Rosalind, a specialised AI model designed for life sciences. Built to assist researchers with complex biological problems, ...

Artificial intelligence is already proving it can accelerate drug development and improve our understanding of disease. But ...

Credit: VentureBeat made with OpenAI GPT-Image-1.5 The journey from a laboratory hypothesis to a pharmacy shelf is one of the ...

A new study helps explain why a promising class of cancer drugs has often failed to meet expectations in clinical trials.

A study reveals how proteins form temporary clusters to manage cellular damage, and how disruptions in this process may lead ...

Inside every cell, a cleanup operation runs around the clock. Proteins are constantly damaged by wear and tear. Some can be repaired, while others must be dismantled and recycled. When this system ...

Inside every cell, a cleanup operation runs around the clock. Proteins are constantly damaged by wear and tear. Some can be ...

A research team at Leipzig University has identified a mechanism in adhesion G protein-coupled receptors (adhesion GPCRs), a ...

Inside every cell, a cleanup operation runs around the clock. Proteins are constantly damaged by wear and tear. Some can be repaired, while others ...

In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...